文献速递神经MR

弥散张量成像血管周围间隙分析(DTI-ALPS)作为胶质瘤类淋巴功能障碍影像生物标志物的系统评价与荟萃分析

Diffusion Tensor Imaging Analysis Along the Perivascular Space (DTI-ALPS) as an Imaging Biomarker of Glymphatic Dysfunction in Gliomas: A Systematic Review and Meta-Analysis.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-08-13

该系统评价与荟萃分析纳入7个比较队列(628例胶质瘤患者和309例健康对照),评估DTI-ALPS指数差异。结果显示胶质瘤患者ALPS指数显著低于健康对照(MD=-0.18,95%CI -0.23至-0.14,P<.00001,I2=70%);低级别胶质瘤ALPS指数高于高级别胶质瘤(MD=0.11,95%CI 0.01-0.21,P=.03,I2=96%);IDH突变状态和肿瘤侧别差异无统计学意义。提示DTI-ALPS是反映疾病相关脑液体转运功能障碍的有前景的无创生物标志物,但需前瞻性验证。

要点

  • 胶质瘤患者DTI-ALPS指数较健康对照显著降低,提示类淋巴弥散功能受损。
  • 低级别胶质瘤ALPS指数高于高级别胶质瘤,但异质性高(I2=96%)。
  • IDH突变状态及肿瘤侧别与ALPS指数无显著关联,结论尚不确定。

诊断标准与关键数值

  • 胶质瘤患者与健康对照的ALPS指数平均差为-0.18(95%CI -0.23至-0.14,P<.00001,I2=70%)。
  • 低级别胶质瘤与高级别胶质瘤的ALPS指数平均差为0.11(95%CI 0.01-0.21,P=.03,I2=96%)。
  • IDH突变型与IDH野生型胶质瘤的ALPS指数平均差为0.09(95%CI -0.01至0.18,P=.07,I2=95%)。
  • 肿瘤同侧与对侧大脑半球的ALPS指数平均差为-0.04(95%CI -0.08至0.01,P=.12,I2=78%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Diffusion tensor imaging analysis along the perivascular space (DTI-ALPS) is an noninvasive MRI biomarker of perivascular/glymphatic diffusivity. Although individual studies suggest that gliomas are associated with disrupted glymphatic function, the magnitude and consistency of DTI-ALPS alterations have not been systematically evaluated.

PURPOSE: To systematically evaluate DTI-ALPS-index differences between glioma patients and healthy controls and to investigate associations with tumor grade, Isocitrate Dehydrogenase(IDH) mutation status, and tumor laterality.

DATA SOURCES: PubMed, Embase, and Scopus were searched from database inception through May 2026.

STUDY SELECTION: Human studies reporting DTI-ALPS-index values in glioma patients and healthy controls were included.

DATA ANALYSIS: Mean differences(MDs) were pooled using random-effects inverse-variance meta-analysis.

DATA SYNTHESIS: Seven comparator cohorts including 628 glioma patients and 309 healthy controls were included. Glioma patients demonstrated significantly lower ALPS-index values than healthy controls(MD, -0.18; 95% CI, -0.23 to -0.14; P<.00001; I2=70%). Lower-grade gliomas had higher ALPS-index values than higher-grade gliomas(MD, 0.11; 95% CI, 0.01-0.21; P=.03; I2=96%). The primary differences between IDH-mutant and IDH-wildtype gliomas(MD, 0.09; 95% CI, -0.01 to 0.18; P=.07; I2=95%) and between tumor-ipsilateral and contralateral hemispheres(MD, -0.04; 95% CI, -0.08 to 0.01; P=.12; I2=78%) were not statistically significant. Exploratory sensitivity analyses excluding one influential cohort yielded statistically significant grade-, IDH-, and laterality-based differences with reduced heterogeneity; however, these findings were dependent on cohort exclusion and should be considered hypothesis-generating.

LIMITATIONS: The evidence is limited by few studies, high heterogeneity, methodological differences in DTI-ALPS measurement, and observational study designs, with some subgroup results changing when individual cohorts are excluded.

CONCLUSIONS: Gliomas are associated with reduced DTI-ALPS-index values compared with healthy controls, indicating impaired perivascular/glymphatic diffusivity. However, associations with tumor grade, IDH status, and laterality remain uncertain due to heterogeneity and sensitivity to individual studies. DTI-ALPS is a promising noninvasive biomarker of disease-associated brain-fluid transport dysfunction, but requires prospective validation, including in studies of transport-modulating interventions.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Shah SR, Qazi MS, Riyyan M, et al. Diffusion Tensor Imaging Analysis Along the Perivascular Space (DTI-ALPS) as an Imaging Biomarker of Glymphatic Dysfunction in Gliomas: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol. 2026. PMID: 42595463. doi:10.3174/ajnr.A9593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。